Binding of αvβ1 and αvβ6 integrins to tenascin-C induces epithelial-mesenchymal transition-like change of breast cancer cells

Oncogenesis

Volumn 2, Issue , 2013, Pages

  Katoh, D ^a   Nagaharu, K ^a   Shimojo, N ^a,b   Hanamura, N ^a   Yamashita, M ^a   Kozuka, Y ^a   Imanaka Yoshida, K ^a,b   Yoshida, T ^a,b  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTEGRIN; ALPHAVBETA1 INTEGRIN; ALPHAVBETA6 INTEGRIN; BETA1 INTEGRIN; BETA6 INTEGRIN; CD51 ANTIGEN; FOCAL ADHESION KINASE; HETERODIMER; INTEGRIN; MESSENGER RNA; NEUTRALIZING ANTIBODY; TENASCIN; TRANSFORMING GROWTH FACTOR BETA1; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; EPITHELIAL MESENCHYMAL TRANSITION; FOCAL ADHESION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; UPREGULATION;

EID: 84883188295     PISSN: None     EISSN: 21579024     Source Type: Journal    
DOI: 10.1038/oncsis.2013.27     Document Type: Article

References (49)

1. Orend G, Chiquet-Ehrismann R. Tenascin-C induced signaling in cancer. Cancer Lett 2006; 244: 143-163.
2. Midwood KS, Orend G. The role of tenascin-C in tissue injury and tumorigenesis. J. Cell Commun Signal 2009; 3: 287-310.
3. Midwood KS, Hussenet T, Langlois B, Orend G. Advances in tenascin-C biology. Cell Mol Life Sci 2011; 68: 3175-3199.
4. Yoshida T, Matsumoto E, Hanamura N, Kalembeyi I, Katsuta K, Ishihara A et al. Co-expression of tenascin and fibronectin in epithelial and stromal cells of benign lesions and ductal carcinomas in the human breast. J Pathol 1997; 182: 421-428.
5. Ishihara A, Yoshida T, Tamaki H, Sakakura T. Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance. Clin Cancer Res 1995; 1: 1035-1041.
6. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008; 451: 147-152.
7. Oskarsson T, Acharyya S, Zhang XH, Vanharanta S, Tavazoie SF, Morris PG et al. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med 2011; 17: 867-874.
8. Yoshida T, Yoshimura E, Numata H, Sakakura Y, Sakakura T. Involvement of tenascin-C in proliferation and migration of laryngeal carcinoma cells. Virchows Arch 1999; 435: 496-500.
9. Tsunoda T, Inada H, Kalembeyi I, Imanaka-Yoshida K, Sakakibara M, Okada R et al. Involvement of large tenascin-C splice variants in breast cancer progression. Am J Pathol 2003; 162: 1857-1867.
10. Calvo A, Catena R, Noble MS, Carbott D, Gil-Bazo I, Gonzalez-Moreno O et al. Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis. Oncogene 2008; 27: 5373-5384.
11. Hancox RA, Allen MD, Holliday DL, Edwards DR, Pennington CJ, Guttery DS et al. Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms. Breast Cancer Res 2009; 11: R24.
12. Kalembeyi I, Inada H, Nishiura R, Imanaka-Yoshida K, Sakakura T, Yoshida T. Tenascin-C upregulates matrix metalloproteinase-9 in breast cancer cells: direct and synergistic effects with transforming growth factor beta1. Int J Cancer 2003; 105: 53-60.
13. Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA. Epithelialmesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest 2009; 119: 1438-1449.
14. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-890.
15. Jahkola T, Toivonen T, von Smitten K, Blomqvist C, Virtanen I. Expression of tenascin in invasion border of early breast cancer correlates with higher risk of distant metastasis. Int J Cancer 1996; 69: 445-447.
16. Jahkola T, Toivonen T, Virtanen I, Von Smitten K, Nordling S, von Boguslawski K et al. Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence. Br J Cancer 1998; 78: 1507-1513.
17. Jahkola T, Toivonen T, Nordling S, von Smitten K, Virtanen I. Expression of tenascin-C in intraductal carcinoma of human breast: relationship to invasion. Eur J Cancer 1998; 34: 1687-1692.
18. Nagaharu K, Zhang X, Yoshida T, Katoh D, Hanamura N, Kozuka Y et al. Tenascin C induces epithelial-mesenchymal transition-like change accompanied by SRC activation and focal adhesion kinase phosphorylation in human breast cancer cells. Am J Pathol 2011; 178: 754-763.
19. Avizienyte E, Wyke AW, Jones RJ, McLean GW, Westhoff MA, Brunton VG et al. Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signaling. Nat Cell Biol 2002; 4: 632-638.
20. Bates RC, Bellovin DI, Brown C, Maynard E, Wu B, Kawakatsu H et al. Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J Clin Invest 2005; 115: 339-347.
21. Ramos DM, Dang D, Sadler S. The role of the integrin alpha v beta6 in regulating the epithelial to mesenchymal transition in oral cancer. Anticancer Res 2009; 29: 125-130.
22. Richter P, Umbreit C, Franz M, Berndt A, Grimm S, Uecker A et al. EGF/TGFb1 co-stimulation of oral squamous cell carcinoma cells causes an epithelialmesenchymal transition cell phenotype expressing laminin 332. J Oral Pathol Med 2011; 40: 46-54.
23. Galliher AJ, Schiemann WP. Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells. Breast Cancer Res 2006; 8: R42.
24. Gupta SK, Oommen S, Aubry MC, Williams BP, Vlahakis NE. Integrin a9b1 promotes malignant tumor growth and metastasis by potentiating epithelialmesenchymal transition. Oncogene 2013; 32: 141-150.
25. Shintani Y, Fukumoto Y, Chaika N, Svoboda R, Wheelock MJ, Johnson KR. Collagen I-mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1. J Cell Biol 2008; 180: 1277-1289.
26. Wayner EA, Gil SG, Murphy GF, Wilke MS, Carter WG. Epiligrin, a component of epithelial basement membranes, is an adhesive ligand for alpha 3 beta 1 positive T lymphocytes. J. Cell Biol 1993; 121: 1141-1152.
27. Allen MD, Vaziri R, Green M, Chelala C, Brentnall AR, Dreger S et al. Clinical and functional significance of a9b1 integrin expression in breast cancer: a novel cell-surface marker of the basal phenotype that promotes tumour cell invasion. J Pathol 2011; 223: 646-658.
28. Blick T, Widodo E, Hugo H, Waltham M, Lenburg ME, Neve RM et al. Epithelial mesenchymal transition traits in human breast cancer cell lines. Clin Exp Metastasis 2008; 25: 629-642.
29. Breuss JM, Gallo J, DeLisser HM, Klimanskaya IV, Folkesson HG, Pittet JF et al. Expression of the b6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J Cell Sci 1995; 108: 2241-2251.
30. Haapasalmi K, Zhang K, Tonnesen M, Olerud J, Sheppard D, Salo T et al. Keratinocytes in human wounds express avb6 integrin. J Invest Dermatol 1996; 106: 42-48.
31. Häkkinen L, Hildebrand HC, Berndt A, Kosmehl H, Larjava H. Immunolocalization of tenascin-C, alpha9 integrin subunit, and alphavbeta6 integrin during wound healing in human oral mucosa. J Histochem Cytochem 2000; 48: 985-998.
32. Bandyopadhyay A, Raghavan S. Defining the role of integrin avb6 in cancer. Curr Drug Targets 2009; 10: 645-652.
33. Thomas GJ, Nystrom ML, Marshall JF. Alphavbeta6 integrin in wound healing and cancer of the oral cavity. J Oral Pathol Med 2006; 35: 1-10.
34. Eberlein C, Kendrew J, McDaid K, Alfred A, Kang JS, Jacobs VN et al. A human monoclonal antibody 264RAD targeting avb6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo. Oncogene (e-pub ahead of print 29 October 2012; doi:10.1038/onc.2012.460).
35. Arihiro K, Kaneko M, Fujii S, Inai K, Yokosaki Y. Significance of alpha 9 beta 1 and alpha v beta 6 integrin expression in breast carcinoma. Breast Cancer (Tokyo, Japan) 2000; 7: 19-26.
36. Yang GY, Xu KS, Pan ZQ, Zhang ZY, Mi YT, Wang JS et al. Integrin alpha v beta 6 mediates the potential for colon cancer cells to colonize in and metastasize to the liver. Cancer Sci 2008; 99: 879-887.
37. Zhang ZY, Xu KS, Wang JS, Yang GY, Wang W, Wang JY et al. Integrin alphavbeta6 acts as a prognostic indicator in gastric carcinoma. Clin Oncol 2008; 20: 61-66.
38. Impola U, Uitto VJ, Hietanen J, Hakkinen L, Zhang L, Larjava H et al. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. J Pathol 2004; 202: 14-22.
39. Regezi JA, Ramos DM, Pytela R, Dekker NP, Jordan RC. Tenascin and beta 6 integrin are overexpressed in floor of mouth in situ carcinomas and invasive squamous cell carcinomas. Oral Oncol 2002; 38: 332-336.
40. Ljubimov AV, Saghizadeh M, Pytela R, Sheppard D, Kenney MC. Increased expression of tenascin-C-binding epithelial integrins in human bullous keratopathy corneas. J Histochem Cytochem 2001; 49: 1341-1350.
41. Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999; 96: 319-328.
42. Wipff PJ, Hinz B. Integrins and the activation of latent transforming growth factor beta1-An intimate relationship. Eur J Cell Biol 2008; 87: 601-615.
43. Vogel BE, Tarone G, Giancotti FG, Gailit J, Ruoslahti E. A novel fibronectin receptor with an unexpected subunit composition (alpha v beta 1). J Biol Chem 1990; 265: 5934-5937.
44. Hu DD, Lin EC, Kovach NL, Hoyer JR, Smith JW. A biochemical characterization of the binding of osteopontin to integrins alpha v beta 1 and alpha v beta 5. J Biol Chem 1995; 270: 26232-26238.
45. Milner R, Edwards G, Streuli C, Ffrench-Constant C. A role in migration for the alpha V beta 1 integrin expressed on oligodendrocyte precursors. J Neurosci 1996; 16: 7240-7252.
46. Deryugina EI, Bourdon MA. Tenascin mediates human glioma cell migration and modulates cell migration on fibronectin. J Cell Sci 1996; 109: 643-652.
47. Koivisto L, Grenman R, Heino J, Larjava H. Integrins alpha5beta1, alphavbeta1, and alphavbeta6 collaborate in squamous carcinoma cell spreading and migration on fibronectin. Exp Cell Res 2000; 255: 10-17.
48. Sriramarao P, Mendler M, Bourdon MA. Endothelial cell attachment and spreading on human tenascin is mediated by alpha 2 beta 1 and alpha v beta 3 integrins. J Cell Sci 1993; 105: 1001-1012.
49. Ramos DM, Chen BL, Boylen K, Stern M, Kramer RH, Sheppard D et al. Stromal fibroblasts influence oral squamous cell carcinoma cell interactions with tenascin-C. Int J Cancer 1997; 72: 369-376.